Compared side by side

Ipamorelin vs tesamorelin: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

They prompt growth hormone release through different receptors: tesamorelin is a GHRH analogue, and ipamorelin a ghrelin receptor agonist that released GH without raising cortisol in animal studies. Tesamorelin is FDA-approved to reduce excess abdominal fat in HIV lipodystrophy, and in two phase 3 trials it cut visceral fat about 15% in 26 weeks; ipamorelin was never approved. Tesamorelin is taken daily, ipamorelin 2–3 times a day.

Side by side

ComparedIpamorelinTesamorelin
CategoryGrowth hormoneGrowth hormone
Also known asIPAMEgrifta
What it isConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.The only GHRH analog currently FDA-approved (to reduce excess abdominal fat in HIV lipodystrophy).
How it worksSelective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.Synthetic GHRH analogue FDA-approved for HIV-associated lipodystrophy. Stimulates GH secretion, reduces visceral adiposity, and improves body composition. Its half-life is short, close to sermorelin's (8–11 minutes on the current labels).
Commonly reportedDeeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.Waist and belly shrinking while body weight barely moves, with injection-site redness and early joint aches.
Studied rangeResearch range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.Research range: 1–2 mg. Studied in research — not a recommendation. FDA-approved as Egrifta WR (1.28 mg) and Egrifta SV (1.4 mg), SubQ once daily, to reduce excess abdominal fat in adults with HIV lipodystrophy.
How often2–3x daily, best fasted or before bedDaily
Half-life~2 hours (measured in healthy men, given IV)~8–11 min (current EGRIFTA SV/WR labels; the original label listed ~26 min)
RouteSubQ injection, IM injectionSubQ injection
Typical runCommonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.FDA approval context: daily use. Community typically runs 12–24 weeks. Reassess at 3 months.
EvidenceModerate: animal studies + some human dataEstablished: clinical trials or FDA-approved use exists
Common side effectsHeadache, flushing, nausea, water retention, numbness/tinglingInjection site reaction, fluid retention, joint pain, nausea, glucose dysregulation

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking ipamorelin or tesamorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

Ipamorelin

  • Day 1–14 Sleep is deepening
  • Day 14–28 Recovery is noticeably faster
  • Day 28–56 Body composition shifts showing up
  • Day 56–84 Cycle-end + planned break

Every card for ipamorelin, with its sources

Tesamorelin

  • Day 1–14 Targeting the deep belly fat
  • Day 14–56 Visceral fat is mobilizing

Every card for tesamorelin, with its sources

Together or one or the other

Ipamorelin and tesamorelin are a common stack: tesamorelin lists ipamorelin among its common stacks.

Questions people ask

How long do ipamorelin and tesamorelin last?

The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV). The half-life of tesamorelin is ~8–11 min (current EGRIFTA SV/WR labels; the original label listed ~26 min).

How often are ipamorelin and tesamorelin taken?

Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection. Tesamorelin: daily. Route: SubQ injection.

How are ipamorelin and tesamorelin dosed in research?

The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. Studied in research — not a recommendation. The research range for tesamorelin is 1–2 mg. Studied in research — not a recommendation. FDA-approved as Egrifta WR (1.28 mg) and Egrifta SV (1.4 mg), SubQ once daily, to reduce excess abdominal fat in adults with HIV lipodystrophy.

What are the common side effects of ipamorelin and tesamorelin?

For ipamorelin, the library lists: headache, flushing, nausea, water retention, numbness/tingling. For tesamorelin: injection site reaction, fluid retention, joint pain, nausea, glucose dysregulation.

Are ipamorelin and tesamorelin taken together?

Ipamorelin and tesamorelin are a common stack: tesamorelin lists ipamorelin among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking ipamorelin or tesamorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo